ID: ALA5197208

Max Phase: Preclinical

Molecular Formula: C24H24N4O

Molecular Weight: 384.48

Associated Items:

Representations

Canonical SMILES:  Cc1nn(-c2ccccc2C(C)C)c(C)c1C(=O)Nc1ccc2ccccc2n1

Standard InChI:  InChI=1S/C24H24N4O/c1-15(2)19-10-6-8-12-21(19)28-17(4)23(16(3)27-28)24(29)26-22-14-13-18-9-5-7-11-20(18)25-22/h5-15H,1-4H3,(H,25,26,29)

Standard InChI Key:  KIOJRFVRPOFEOI-UHFFFAOYSA-N

Associated Targets(Human)

Protein Wnt-3a 90 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 384.48Molecular Weight (Monoisotopic): 384.1950AlogP: 5.41#Rotatable Bonds: 4
Polar Surface Area: 59.81Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 2.39CX LogP: 5.48CX LogD: 5.48
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.51Np Likeness Score: -1.57

References

1. Ai Y, Sakamuru S, Imler G, Xia M, Xue F..  (2022)  Improving the solubility and antileukemia activity of Wnt/β-catenin signaling inhibitors by disrupting molecular planarity.,  69  [PMID:35777269] [10.1016/j.bmc.2022.116890]

Source